Core Viewpoint - The company emphasizes that the recent shareholder reduction in holdings is a normal market behavior based on individual financial arrangements and market conditions, and it adheres to information disclosure regulations [1] Group 1: Shareholder Actions - The company states that the shareholder reduction is a voluntary decision and reflects normal market behavior [1] - The company will disclose changes in shareholder holdings in its periodic reports [1] Group 2: Business Strategy - The chairman and management are focused on the development of the core business, implementing a dual-driven strategy of "biological fermentation + synthetic biology" [1] - The company aims to enhance its core competitiveness through technological innovation and cost control [1] Group 3: Governance and Compliance - The company is committed to maintaining standardized operations and optimizing its governance structure [1] - It will fulfill its information disclosure obligations in accordance with regulatory requirements for any significant matters [1]